Publications

Hanna LA, Clegg MS, Momma T, Rogers JM, Daston GP, Keen CL. 2003. Zinc influences the in vitro development of peri-implantation mouse embryos. Birth Defects Res A 67(6):414–420; doi: 10.1002/bdra.10046.

Leazer TM, Daston GP, Keen CL, Rogers JM. 2003. The embryolethality of lipopolysaccharide in CD-1 and metallothionein I-II null mice: Lack of a role for induced zinc deficiency or metallothionein induction. Toxicol Sci 73(2):442–447; doi: 10.1093/toxsci/kfg088.

Tarka-Leeds DK, Suarez JD, Roberts NL, Rogers JM, Hardy MP, Klinefelter GR. 2003. Gestational exposure to ethane dimethanesulfonate permanently alters reproductive competence in the CD-1 mouse. Biol Reprod 69(3):959–967; doi: 10.1095/biolreprod.103.017343.

Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74(2):369–381; doi: 10.1093/toxsci/kfg121.

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74(2):382–292; doi: 10.1093/toxsci/kfg122.

Rogers JM, Abbott BD. 2003. Screening for developmental toxicity of tobacco smoke constituents. Toxicol Sci 75(2):227–228; doi: 10.1093/toxsci/kfg215.

Rogers EH, Hunter ES, Rosen MB, Rogers JM, Lau C, Hartig PC, Francis BM, Chernoff N. 2003. Lack of evidence for intergenerational reproductive effects due to prenatal and postnatal undernutrition in the female CD-1 mouse. Reprod Toxicol 17:519–525; doi: 10.1016/s0890-6238(03)00070-4.

Tarka-Leeds DK, Herr DW, Klinefelter GR, Rogers JM. 2003. Effects of gestational exposure to ethane dimethanesulfonate in CD-1 mice: Microtia and preliminary hearing tests. Birth Defects Res B 68(4):383–390; doi: 10.1002/bdrb.10033.

Rogers JM, Setzer RW, Branch S, Chernoff N. 2003. Chemically-induced supernumerary ribs in CD-1 mice: Size distribution and dose-response. Birth Defects Res B 71(1):17–25; doi: 10.1002/bdrb.10055.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B 68(6):465–471; doi: 10.1002/bdrb.10046.

Sarangapani R, Gentry PR, Covington TR, Teeguarden JG, and Clewell HJ. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal Toxicol 15(10):987–1016.

Gentry PR, Covington TR, Clewell HJ, Andersen ME. 2003. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J Toxicol Environ Health A 66(23):2209–2225.

Choksi NY, Jahnke GD, St Hilaire C, Shelby MD. 2003. Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res B Develop Reprod Toxicol 68(6):479–491; doi: 10.1210/er.2015-1106.

Grant RL, Rodriguez R, Hofelt CS, and Haws LC. 2002. Shortcomings in USEPA’s approach for predicting risk due to consumption of animal food products impacted by air emissions from hazardous waste combustion facilities: A case study involving phthalates. Human Ecol Risk Assess 8(5):1137-1154; doi: 10.1080/1080-700291905855.

Roberts SM, Jordan KE, Warren DA, Britt JK, James RC. 2002. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride). Regul Toxicol Pharmacol 35(1):44-55; doi: 10.1006/rtph.2001.1518.

Clewell HJ, Teeguarden J, McDonald T, Sarangapani R, Lawrence G, Covington T, Gentry R, Shipp A. 2002. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit Rev Toxicol 32(5):329–389.

Hofelt CS, Honeycutt M, McCoy JT, Haws LC. 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol 33(1):60-65; doi: 10.1006/rtph.2000.1438.

Gentry PR, Covington TR, Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 36:51–68.

Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metabol 2(2):199–214; doi: 10.2174/1389200013338577.

Booth RG, Moniri NH, Bakker RA, Choksi NY, Nix WB, Timmerman H, Leurs R. 2002. A novel phenylaminotetralin radioligand reveals a sub-population of histamine H1 receptors. J Pharmacol Exper Therapeut 302(1):328–336; doi: 10.1124/jpet.302.1.328.